Literature DB >> 17712283

Relationship between P50 suppression and the cortical silent period.

Bertram Möller1, Gregory A Light, Paul B Fitzgerald, Joel S Snyder, Robert Chen, Zafiris J Daskalakis.   

Abstract

Deficient inhibitory neurotransmission has been demonstrated in schizophrenia through electroencephalography (e.g. P50 suppression) and transcranial magnetic stimulation (e.g. short-interval cortical inhibition and the cortical silent period). It is not known whether these inhibitory paradigms are related despite evidence suggesting that both are coordinated through gamma-aminobutyric acid inhibitory neurotransmission. We explored the relationship between P50 suppression, short-interval cortical inhibition and the cortical silent period in 21 healthy participants using previously published methods. P50 suppression was significantly correlated with cortical silent period (r=-0.49, P=0.02) but not with short-interval cortical inhibition. As both P50 suppression and the cortical silent period have been linked to gamma-aminobutyric acidB receptor-mediated inhibitory neurotransmission, these data highlight the importance of this receptor subtype in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17712283     DOI: 10.1097/WNR.0b013e3282ef6a29

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients.

Authors:  Klevest Gjini; Ulf Ziemann; T Celeste Napier; Nash Boutros
Journal:  J Psychiatr Res       Date:  2011-10-27       Impact factor: 4.791

2.  Persistent motor system abnormalities in formerly concussed athletes.

Authors:  Louis De Beaumont; David Mongeon; Sébastien Tremblay; Julie Messier; François Prince; Suzanne Leclerc; Maryse Lassonde; Hugo Théoret
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

3.  Dissociation of motor task-induced cortical excitability and pain perception changes in healthy volunteers.

Authors:  Magdalena S Volz; Mariana Mendonca; Fernando S Pinheiro; Huashun Cui; Marcus Santana; Felipe Fregni
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.